The European Medicines Agency is seeking feedback on the best possible approaches it can use to balance clinical trial transparency with confidentiality requirements in the publication of information that is submitted through the EU’s Clinical Trials Information System (CTIS).
Specifically, the agency wants to learn how to achieve this balance “while simplifying the modalities of use of CTIS to...